The American Thoracic Society (ATS) guideline for hospital-acquired pneumonia (HAP)
released in 1996 and the Trouillet classification published in 1998 supply different rational …

Adequate antimicrobial therapy is a main approach employed to decrease the mortality
associated with hospital-acquired pneumonia (HAP). All methods that optimise empirical …

The most important manuscript on the field of respiratory infections in ICU in 2005 was the
American Thoracic Society (ATS)/Infectious Disease Society of North America (IDSA) …

Background The 2005 guidelines of the American Thoracic Society-Infectious Diseases
Society of America Guidelines for Hospital for managing hospital-acquired pneumonia …

Nosocomial pneumonia occurs in 0.5 to 1.5% of all hospitalized patients and in 10 to 30% of
those under artificial ventilation. The main causal agents are Staphylococcus aureus and …

Background While current guidelines recommend consideration of local microbiologic data
when selecting empiric treatment for hospital-acquired pneumonia (HAP), few specifics of …

Study objectives To asses the impact of locally developed antimicrobial treatment guidelines
in the initial empiric treatment of ICU patients with severe hospital-acquired pneumonia …

Of the 16 024 patients hospitalized from January 1995 to October 1997, 397 (2.4%) acquired
nosocomial pneumonia and the aetiological agent was defined in 101 (25%). About 82 …

Nosocomial pneumonia or hospital-acquired pneumonia (HAP) causes considerable
morbidity and mortality. It is the second most common nosocomial infection and the leading …

Duration of antimicrobial therapy 658 Antibiotic heterogeneity and antibiotic cycling 659
References 660 pathogens in the selection of initial therapy in at-risk patients. Iregui et al …